Saltar al contenido
MilliporeSigma
Todas las fotos(1)

Key Documents

H4784

Sigma-Aldrich

Heparina sodium salt from porcine intestinal mucosa

≥180 USP units/mg

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Número de CAS:
9041-08-1
MDL number:
MFCD00081689
UNSPSC Code:
12352201
NACRES:
NA.21

biological source

Porcine intestinal mucosa

Quality Level

200

form

powder

specific activity

≥180 USP units/mg

solubility

H2O: 50 mg/mL, clear, colorless to faintly yellow

cation traces

Ca: ≤20 ppm

storage temp.

2-8°C

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

Our comprehensive portfolio of downstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Ranging from non-GMP grades for low-risk application, to IPEC-PQG GMP for higher-risk applications, we have products covering all your manufacturing needs.

Quality

Low calcium content

Storage Class

11 - Combustible Solids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
SLCC4685
SLBQ1351V
SLBP3704V
SLBN0543V
SLBF3813V

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 3

1 of 3

Heparin lithium salt from porcine intestinal mucosa ≥150 USP units/mg

Sigma-Aldrich

H0878

Heparin lithium salt from porcine intestinal mucosa

vibrant-m

Y0001282

Heparina sodium salt

vibrant-m

D0070000

Heparina sodium salt

Linda Cruz et al.
PloS one, 8(7), e68379-e68379 (2013-07-19)
Human papillomavirus (HPV) infection is the leading cause of cervical cancer world-wide. Here, we show that native HPV particles produced in a differentiated epithelium have developed different strategies to infect the host. Using biochemical inhibition assays and glycosaminoglycan (GAG)-negative cells
Eve Draper et al.
PloS one, 8(5), e61825-e61825 (2013-05-08)
The current generation of Human Papillomavirus (HPV) vaccines, Cervarix® and Gardasil®, exhibit a high degree of efficacy in clinical trials against the two high-risk (HR) genotypes represented in the vaccines (HPV16 and HPV18). High levels of neutralizing antibodies are elicited
Felix J Hartmann et al.
Cell reports, 28(3), 819-831 (2019-07-18)
The success of immunotherapy has led to a myriad of clinical trials accompanied by efforts to gain mechanistic insight and identify predictive signatures for personalization. However, many immune monitoring technologies face investigator bias, missing unanticipated cellular responses in limited clinical
Sara L Bissett et al.
Scientific reports, 6, 39730-39730 (2016-12-23)
The human papillomavirus (HPV) vaccines consist of major capsid protein (L1) virus-like particles (VLP) and are highly efficacious against the development of cervical cancer precursors attributable to oncogenic genotypes, HPV16 and HPV18. A degree of vaccine-induced cross-protection has also been
William H Thiel et al.
PloS one, 7(9), e43836-e43836 (2012-09-11)
The broad applicability of RNA aptamers as cell-specific delivery tools for therapeutic reagents depends on the ability to identify aptamer sequences that selectively access the cytoplasm of distinct cell types. Towards this end, we have developed a novel approach that
Ver todos los artículos relacionados

Artículos

Glycosaminoglycan Sulfation and Signaling

Glycosaminoglycans are large linear polysaccharides constructed of repeating disaccharide units.

Protocolos

Trophoblast Protocol

This protocol describes a method for culturing TS cell lines. These cells can then be used to study trophoblast differentiation and placental function.

RNAi In Situ

In Situ Hybridization of Whole-Mount Mouse Embryos with RNA Probes: Hybridization, Washes, and Histochemistry. This is a protocol describing how to perform in situ hybridization on whole mouse embryos. Here we describe the hybridization procedure, and the localization of the DIG-labeled RNA using a conjugate of anti-DIG Fab antibody and calf intestinal alkaline phosphatase. Enzyme activity of the reporter is detected by a color reaction, resulting in the formation of a water-insoluble purple/blue precipitate. Manipulating the Mouse Embryo - Third Edition

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico